Isha Rani

888 total citations
50 papers, 658 citations indexed

About

Isha Rani is a scholar working on Molecular Biology, Nutrition and Dietetics and Pharmacology. According to data from OpenAlex, Isha Rani has authored 50 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Nutrition and Dietetics and 8 papers in Pharmacology. Recurrent topics in Isha Rani's work include Synthesis and biological activity (7 papers), Trace Elements in Health (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Isha Rani is often cited by papers focused on Synthesis and biological activity (7 papers), Trace Elements in Health (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Isha Rani collaborates with scholars based in India, Italy and Lebanon. Isha Rani's co-authors include Sarah Shefer, G Salen, Amit Pal, Navneet Agnihotri, G. Stephen Tint, F. G. Zaki, G C Ness, Hardeep Singh Tuli, Seema Ramniwas and Rosanna Squitti and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Isha Rani

44 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isha Rani India 15 217 155 117 98 79 50 658
Mei-Due Yang Taiwan 17 344 1.6× 71 0.5× 80 0.7× 103 1.1× 89 1.1× 26 792
Kok-Lun Pang Malaysia 17 268 1.2× 68 0.4× 67 0.6× 133 1.4× 45 0.6× 30 747
Alaa E. El‐Sisi Egypt 17 312 1.4× 82 0.5× 114 1.0× 48 0.5× 107 1.4× 58 958
Bikash Manandhar Australia 17 417 1.9× 122 0.8× 64 0.5× 97 1.0× 75 0.9× 35 1.0k
Kenji Ikemura Japan 15 299 1.4× 69 0.4× 189 1.6× 47 0.5× 86 1.1× 49 775
Riyad A. Almaimani Saudi Arabia 16 208 1.0× 44 0.3× 103 0.9× 93 0.9× 52 0.7× 51 730
Yasushi Ohno Japan 19 326 1.5× 94 0.6× 135 1.2× 28 0.3× 83 1.1× 61 1.0k
Muobarak J. Tuorkey Egypt 13 386 1.8× 69 0.4× 91 0.8× 46 0.5× 101 1.3× 25 971
Mario D’Ambrosio Italy 19 348 1.6× 67 0.4× 60 0.5× 49 0.5× 39 0.5× 44 956
Wenbo Ding China 13 422 1.9× 97 0.6× 57 0.5× 48 0.5× 56 0.7× 42 860

Countries citing papers authored by Isha Rani

Since Specialization
Citations

This map shows the geographic impact of Isha Rani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isha Rani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isha Rani more than expected).

Fields of papers citing papers by Isha Rani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isha Rani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isha Rani. The network helps show where Isha Rani may publish in the future.

Co-authorship network of co-authors of Isha Rani

This figure shows the co-authorship network connecting the top 25 collaborators of Isha Rani. A scholar is included among the top collaborators of Isha Rani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isha Rani. Isha Rani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rani, Lata, Isha Rani, Rupesh K. Gautam, et al.. (2025). Therapeutic potential of protein–protein interaction modulators in antiviral research. Bioorganic Chemistry. 168. 109346–109346.
2.
Rath, Prangya, Abhishek Chauhan, Anuj Ranjan, et al.. (2024). Luteolin: A promising modulator of apoptosis and survival signaling in liver cancer. Pathology - Research and Practice. 260. 155430–155430. 7 indexed citations
3.
Kumar, Manish, et al.. (2023). In-Silico Design, Synthesis, and Pharmacological Evaluation of Oxadiazole-Based Selective Cyclo-oxygenase-2 Inhibitors. Assay and Drug Development Technologies. 21(4). 166–179. 2 indexed citations
4.
Sethi, Gautam, Prangya Rath, Abhishek Chauhan, et al.. (2023). Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements. Pharmaceutics. 15(2). 712–712. 69 indexed citations
5.
Rani, Isha, Prakasini Satapathy, Anmol Goyal, et al.. (2023). Viral Loads in Skin Samples of Patients with Monkeypox Virus Infection: A Systematic Review and Meta-Analysis. Viruses. 15(6). 1386–1386. 5 indexed citations
6.
Rani, Isha, Hemant Joshi, Ujjawal Sharma, et al.. (2023). Potential use of cidofovir, brincidofovir, and tecovirimat drugs in fighting monkeypox infection: recent trends and advancements. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(4). 2055–2065. 10 indexed citations
7.
Joshi, Hemant, Dhruv Gupta, Ginpreet Kaur, et al.. (2023). Genistein: a promising modulator of apoptosis and survival signaling in cancer. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(11). 2893–2910. 16 indexed citations
8.
9.
Tuli, Hardeep Singh, Hemant Joshi, Seema Ramniwas, et al.. (2023). Chemopreventive mechanisms of amentoflavone: recent trends and advancements. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(5). 865–876. 16 indexed citations
10.
Rani, Isha, et al.. (2022). Computational Design of Phosphatidylinositol 3-Kinase Inhibitors. Assay and Drug Development Technologies. 20(7). 317–337. 13 indexed citations
11.
Rani, Isha, et al.. (2021). Potential molecular mechanisms of zinc- and copper-mediated antiviral activity on COVID-19. Nutrition Research. 92. 109–128. 55 indexed citations
12.
Rani, Isha, et al.. (2021). Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma. Molecular and Cellular Biochemistry. 476(3). 1517–1527. 6 indexed citations
13.
Prasad, Rajendra, et al.. (2021). Atypical Case of Highly Mutated h-TERT Promoter in Germline Genome from Buccal Mucosa Cancer. Indian Journal of Clinical Biochemistry. 38(3). 400–404.
14.
Prasad, Rajendra, et al.. (2021). An Integrated Approach of the Potential Underlying Molecular Mechanistic Paradigms of SARS-CoV-2-Mediated Coagulopathy. Indian Journal of Clinical Biochemistry. 36(4). 387–403. 5 indexed citations
15.
Rani, Isha, et al.. (2021). Association of interleukin-18 genotypes (−607C > A) and (−137 G > C) with the hepatitis B virus disease progression to hepatocellular carcinoma. Molecular and Cellular Biochemistry. 476(11). 3923–3933. 3 indexed citations
16.
Goel, Parul, et al.. (2020). Analysis of performance of clinical biochemistry laboratory using Sigma metrics and Quality Goal Index. Practical Laboratory Medicine. 23. e00195–e00195. 11 indexed citations
17.
Agnihotri, Navneet, et al.. (2016). Fish oil prevents colon cancer by modulation of structure and function of mitochondria. Biomedicine & Pharmacotherapy. 82. 90–97. 18 indexed citations
18.
Rani, Isha, Kim Vaiphei, & Navneet Agnihotri. (2014). Supplementation of fish oil augments efficacy and attenuates toxicity of 5-fluorouracil in 1,2-dimethylhydrazine dihydrochloride/dextran sulfate sodium-induced colon carcinogenesis. Cancer Chemotherapy and Pharmacology. 74(2). 309–322. 22 indexed citations
19.
Rani, Isha, et al.. (2013). Alterations in Mitochondrial Membrane in Chemopreventive Action of Fish Oil. Cancer Investigation. 31(4). 231–240. 7 indexed citations
20.
Rani, Isha. (1986). Structural confirmation of eriodictyol 7-methyl ether, a new flavanone occurring in Wyethia glabra Nutt.. 25(12). 1251. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei-Due Yang Breakdown of academic impact, for papers by Kok-Lun Pang Breakdown of academic impact, for papers by Alaa E. El‐Sisi Breakdown of academic impact, for papers by Bikash Manandhar Breakdown of academic impact, for papers by Kenji Ikemura Breakdown of academic impact, for papers by Riyad A. Almaimani Breakdown of academic impact, for papers by Yasushi Ohno Breakdown of academic impact, for papers by Muobarak J. Tuorkey Breakdown of academic impact, for papers by Mario D’Ambrosio Breakdown of academic impact, for papers by Wenbo Ding
Rankless by CCL
2026